- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Haemonetics Corp
+ Add to WatchlistHAE:US
41.0500 USD 0.2300 0.56%As of 13:11:17 ET on 05/24/2013.
Snapshot for Haemonetics Corp (HAE)
| Open: | 41.0400 | Day's Range: | 40.5700 - 41.0500 | Volume: | 70,117 |
|---|---|---|---|---|---|
| Previous Close: | 41.2800 | 52wk Range: | 32.6900 - 44.4400 | 1-Yr Rtn: | +17.29% |
Key Statistics for HAE
| Current P/E Ratio (ttm) | 23.8950 |
|---|---|
| Estimated P/E(03/2014) | 18.8327 |
| Relative P/E vs. SPX | 1.4857 |
| Earnings Per Share (USD) (ttm) | 1.7150 |
| Est. EPS (USD) (03/2014) | 2.1760 |
| Est. PEG Ratio | 1.4771 |
| Market Cap (M USD) | 2,093.12 |
| Shares Outstanding (M) | 51.08 |
| 30 Day Average Volume | 375,056 |
| Price/Book (mrq) | 2.7007 |
| Price/Sale (ttm) | 2.3644 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HAE
Company Profile & Key Executives for HAE
Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company's products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.
| Richard J Meelia "Rich"Non Executive Chairman | Brian P ConcannonPresident/CEO |
| Michael Kelly "Mike"President:North America | Christopher J LindopVP:Business Development/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HAE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page